Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide CME for physicians. Medscape, LLC designates this educational activity for a maximum of 0.75 *AMA PRA Category 1 Credits*™. Physicians should only claim credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation at **<http://www.medscape.com/cme/eid>**; (4) view/print certificate.

Learning Objectives
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Upon completion of this activity, participants will be able to:

-   Identify the criteria used to define severe *Clostridium difficile*--associated disease (CDAD) in the current study

-   Specify the prevalence of severe CDAD in the current study

-   Identify the clinical risk factors for severe CDAD

-   List the laboratory risk factors for severe CDAD
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CME Questions
=============

1.  All of the following were criteria for severe *Clostridium difficile*--associated disease (CDAD) in the current study, except:

    1.  A. One or more intensive care unit admissions in which *C. difficile* was a major contributor

    2.  B. Prolonged symptoms past 14 days requiring intravenous fluid replacement

    3.  C. Colectomy or other surgery directly attributed to *C. difficile*

    4.  D. Intestinal perforation in the setting of *C. difficile* infection

2.  What was the prevalence of severe CDAD among all of the cases of CDAD in the current study?

    1.  A. \<1%

    2.  B. 12%

    3.  C. 29%

    4.  D. 44%

3.  Which of the following patient factors was most associated with an increased risk for severe CDAD on multivariate analysis of the current study?

    1.  A. Age \>70 years

    2.  B. Chemotherapy use

    3.  C. Antimicrobial use

    4.  D. Previous hospital stay

4.  All of the following laboratory factors were predictive of an increased risk for CDAD in the current study, except:

    1.  A. White blood cell count \>20,000 cells/mL

    2.  B. Serum albumin \<2.5 g/dL

    3.  C. Creatinine \>2 mg/dL

    4.  D. Alanine aminotransferase \>40 U/L
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